Devens, MA, United States of America

Ivan Kovacik

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ivan Kovacik

Introduction

Ivan Kovacik is a notable inventor based in Devens, Massachusetts. He has made significant contributions to the field of pharmaceuticals, particularly in the purification of rapamycin derivatives. With a total of six patents to his name, Kovacik's work has advanced the understanding and application of these important compounds.

Latest Patents

Kovacik's latest patents focus on the purification of rapamycin derivatives using temperature-induced phase separation. This innovative method provides techniques for obtaining purified rapamycin derivatives, including the purified form of Biolimus A9. Additionally, a crystalline form of Biolimus A9 is described in his patents, showcasing his commitment to enhancing the quality and efficacy of pharmaceutical products.

Career Highlights

Ivan Kovacik is currently employed at Biosensors International Group, Ltd., where he continues to push the boundaries of pharmaceutical innovation. His work has not only contributed to the company's success but has also had a broader impact on the industry.

Collaborations

Kovacik collaborates with talented professionals in his field, including Margaret W Kayo and Richard S Fornicola. These partnerships enhance the research and development efforts at Biosensors International Group, Ltd.

Conclusion

Ivan Kovacik's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to influence the industry and improve the quality of pharmaceutical products.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…